Givaudan reported 3.93B in Equity Capital and Reserves for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akzo Nobel AKZA:NA € 5448M 23M
Arkema AKE:FP € 6760M 457M
Associated British Foods ABF:LN 10.36B 435M
BASF BAS:GR € 41140M 348M
Bayer BAYN:GR € 37437M 4417M
British American Tobacco BATS:LN 67.1B 4.2B
Covestro 1COV:GR 8.44B 748M
Croda International CRDA:LN 1.75B 100.1M
Diageo DGE:LN 7.66B 761M
Fresenius FRE:GR € 19870M 872M
Fresenius Medical Care FME:GR € 13234.5M 535.71M
Givaudan GIVN:VX 3.93B 277M
Glanbia GLB:ID 1.73B 57.8M
International Flavors Fragrances IFF:US $ 20933M 149M
Johnson Matthey JMAT:LN 2.44B 232M
Kerry Group KYG:ID 5.6B 638.1M
Lonza Group LONN:SW 9.75B 2.48B
Merck MRK:GR € 22919M 1581M
SGS SGSN:VX 1.12B 256M
Solvay SOLB:BB € 9485M 746M
Tate & Lyle TATE:LN 1.62B 112M
Umicore UMI:BB 3.11B 230.98M